年龄只是数字:DIEP皮瓣在不同年龄组中均安全
该研究基于PearlDiver保险理赔数据库6201例患者,比较不同年龄组接受DIEP皮瓣乳房再造的安全性。结果显示,尽管>65岁患者合并症更多,但其90天再入院可能性低于年轻组(18-44岁和45-65岁),且血肿、血清肿、二次手术、皮瓣失败和修整在各年龄组间无统计学显著差异。提示年龄本身不应视为自体乳房再造的禁忌证。
要点
- >65岁患者合并症更多,但90天再入院可能性低于年轻组。
- 各年龄组间血肿、血清肿、二次手术、皮瓣失败和修整无显著差异。
- 年龄本身不应作为自体乳房再造的禁忌证。
核心结论
- 年龄本身不应被视为自体乳房再造的禁忌证,决策应基于患者整体健康状况和意愿的综合评估。
研究设计与样本
- 基于PearlDiver全国保险理赔数据库的回顾性查询,纳入6201例患者,比较不同年龄组(18-44岁、45-65岁、>65岁)接受DIEP皮瓣乳房再造的结局。
主要发现
- >65岁患者合并症更多,但90天再入院可能性低于18-44岁和45-65岁组。
- 各年龄组间血肿、血清肿、二次手术、皮瓣失败和修整的可能性无统计学显著差异。
临床怎么用
- 对于>65岁乳腺癌患者,不应仅因年龄拒绝DIEP皮瓣乳房再造,应综合评估合并症和患者意愿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Breast cancer is the most common malignancy in women, with increasing incidence with age. However, surgeons are often hesitant to offer complex surgical reconstruction to the older patient population due to concerns about safety. A query of 6201 patients identified on PearlDiver, a national insurance claims-based database, revealed that despite older patients (>65) having a higher comorbidity profile, they had a lower likelihood of 90-day readmission compared to the younger age groups (18-44 and 45-65 years old), and no statistically significant differences in likelihood of hematoma, seroma, takebacks, flap failure, and revisions across age groups. These findings suggest that age alone should not be considered a contraindication to autologous breast reconstruction, and that decisions should instead be guided by comprehensive assessment of each patient's overall health status and desires.
引用
- Jeon H, Yum A, Perez-Alvarez I, et al. "Age is just a number": Deep inferior epigastric perforator flaps are safe across different age groups. J Plast Reconstr Aesthet Surg. 2026. PMID: 41831265. doi:10.1016/j.bjps.2026.02.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。